Aclaris Therapeutics, Inc.
ACRSNASDAQ
USReal-Time Price
USReal-Time Price$3.73USD
-0.01 (-0.40%)Today
BTI Score
BASIC required or higher
View pricingBTI Fair Market Cap
$127.80M
Revenue-based (growth phase)
Biotechnology
High Risk
Aclaris Therapeutics, Inc. (ACRS) Business Model
How does Aclaris Therapeutics, Inc. (ACRS) make money? A breakdown of revenue segments, margins, competitive moat and the unit economics behind the business.
Error loading business model: Sign in to load this business model